戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  OxR1 signaling in motivation for the opioid remifentanil.
2 veness of the measure to the analgesic agent remifentanil.
3  at baseline, as well as their changes under remifentanil.
4 y during the withdrawal period of the opioid remifentanil.
5 ion (supramarginal gyrus) were unaffected by remifentanil.
6 short breath hold is modulated by the opioid remifentanil.
7 o-breathe score, was profoundly reduced with remifentanil.
8 edetomidine, with or without the addition of remifentanil.
9  on newly proposed clinical applications for remifentanil.
10 ression (ON-State) of respiration induced by remifentanil.
11 on of opioid drugs, including rapidly acting remifentanil.
12 rdiac ablation under general anesthesia with remifentanil.
13 eceived 0.9% NaCl, 12 received low-dose (LD) remifentanil (0.25 mcg/kg/min), and 11 received high-dos
14  mcg/kg/min), and 11 received high-dose (HD) remifentanil (0.5 mcg/kg/min).
15 /- 1.2 vs 2.6 +/- 1.2 mg/kg/hr; p = 0.23 and remifentanil 1.27 +/- 0.17 vs 1.27 +/- 0.16 mug/kg/hr; p
16 acebo, and two effect site concentrations of remifentanil (1 and 2 microg/ml), an mu-opioid agonist.
17 ificantly attenuated in mice pretreated with remifentanil (159 vs 805 pg/ml of IL-6 after saline pret
18 f succinylcholine or rocuronium; n = 575) or remifentanil (3 to 4 mug/kg; n = 575) immediately after
19 r intraoperative analgesia (100%), alongside remifentanil (71.4%) and oxycodone (24.3%).
20  drug (the short-acting mu receptor agonist, remifentanil) acquires incentive motivational properties
21 is to demonstrate that the administration of remifentanil, an opioid widely used during surgery, can
22 s recorded in 19 of 575 patients (3.3%) with remifentanil and 3 of 575 (0.5%) with neuromuscular bloc
23                                              Remifentanil and expectancy both reduced pain, but drug
24 city) for the potent and short-acting opioid remifentanil and reduced low-effort remifentanil consump
25 oids) and organ ischemia/reperfusion injury (remifentanil and sevoflurane when the heart is available
26 her clinically employed synthetic (fentanyl, remifentanil) and the semisynthetic opioid (oxycodone) w
27 monkeys choose between a short-lived opiate, remifentanil, and a palatable food reward.
28                                              Remifentanil appears particularly attractive for this pu
29 d reports of novel clinical applications for remifentanil are frequently appearing in the anesthesia
30   Second, recent data relating to the use of remifentanil are reviewed.
31 ing jugular catheters engaged in cocaine- or remifentanil-associated lever responding that was fixed
32                         Preconditioning with remifentanil attenuates intestinal IRI and the subsequen
33                       The rapid clearance of remifentanil avoids accumulation of confounding levels o
34 biophysical data to support (+)-naloxone and remifentanil binding to TLR4/MD2.
35 ia with sevoflurane-remifentanil or propofol-remifentanil can keep patients immobile without producin
36 at self-administration of the potent opioid, remifentanil, causes a long-lasting hypoactive basal sta
37 d sequence intubation in the operating room, remifentanil, compared with neuromuscular blockers, did
38 y; alpha) for remifentanil without affecting remifentanil consumption at low effort.
39 creased demand elasticity) without affecting remifentanil consumption at low effort.
40 g opioid remifentanil and reduced low-effort remifentanil consumption.
41 aling (OxR1) within ventral pallidum (VP) in remifentanil demand and cue-induced reinstatement of rem
42 o determine the role of VP OxR1 signaling in remifentanil demand and cue-induced reinstatement of rem
43 the mechanism through which orexin regulates remifentanil demand is currently unknown.
44 intravenous injections of the opioid agonist remifentanil functioned as positive reinforcers in both
45                                              Remifentanil group (dosage subgroups combined) was compa
46 pulation, 374 of 565 patients (66.2%) in the remifentanil group and 403 of 565 (71.3%) in the neuromu
47 curred in 374 of 575 patients (66.1%) in the remifentanil group and 408 of 575 (71.6%) in the neuromu
48                                              Remifentanil group had smaller NadirHbO in inferior mFPC
49                   In fact, the mucosa in the remifentanil group was as healthy as that of sham-operat
50 sensory cortex (S1) to ablation in PL versus remifentanil groups.
51                                              Remifentanil has a place in obstetric anaesthesia and an
52 ntravenous self-administration of the opioid remifentanil in a drug-concentration-dependent manner.
53 e, we investigated the effects of the opioid remifentanil in a large sample (n = 78) of healthy male
54 ave reliable anticonvulsant effects, whereas remifentanil in larger doses and sevoflurane appear to s
55 mmarizes the knowledge to date of the use of remifentanil in obstetric anaesthesia and analgesia.
56 1) antagonism reduces demand for cocaine and remifentanil, indicating that orexin-based therapies may
57                                    Localized remifentanil-induced decreases in breath hold-related ac
58                             We also observed remifentanil-induced decreases in the BOLD response to b
59 yperexcitable thalamocortical networks drive remifentanil-induced hyperalgesia in a rodent model of p
60 ive flexibility, basal hypoactive state, and remifentanil-induced plasticity.
61                                              Remifentanil infusion in acute pain decreases the activa
62                                              Remifentanil is effective at obtunding responses to airw
63                                              Remifentanil is still in its infancy in terms of postmar
64                            Pretreatment with remifentanil markedly reduced intestinal IRI (P < 0.001)
65      Propofol, dexmedetomidine, ketamine and remifentanil may be used in combination with anesthetic
66  Additional opioids recently studied include remifentanil, methadone, tramadol, and codeine.
67 odone, tapentadol, fentanyl, sufentanil, and remifentanil) obtained from the Federal Commission for t
68    We investigated the effects of continuous remifentanil on cortical hemodynamics during cardiac abl
69  receive tail vein injections of 1 mug/kg of remifentanil or normal saline and underwent either ische
70         Moderate anesthesia with sevoflurane-remifentanil or propofol-remifentanil can keep patients
71 as significantly lower than that of cocaine, remifentanil, or buprenorphine in monkeys responding und
72 dation was prevented by preconditioning with remifentanil (P < 0.05).
73 on selected advances in our understanding of remifentanil pharmacokinetics and pharmacodynamics and o
74 ference was detected between the saline- and remifentanil-pretreatments in any of the parameters inve
75 sthesia, such as combination of propofol and remifentanil, provides best preservation of autoregulati
76  handled rats following repeated exposure to remifentanil reveals a suppression of pro-inflammatory c
77 ociated with higher analgesic sensitivity to remifentanil (SaO(2), P = 0.0440; IGFBP-1, P = 0.0013).
78 anil demand and cue-induced reinstatement of remifentanil seeking in male rats.
79 a values predicted the degree of cue-induced remifentanil seeking, and microinjection of SB into VP a
80 a-VP attenuated cue-induced reinstatement of remifentanil seeking.
81 anil demand and cue-induced reinstatement of remifentanil seeking.
82 e, but not hyperactive basal state following remifentanil self-administration aligned with deficits i
83 discovered that pDNA-IL-10 treatment reduces remifentanil self-administration in a drug-concentration
84 although an attenuation of either cocaine or remifentanil self-administration was obtained at the hig
85            (+)-Naloxone also reduced opioid (remifentanil) self-administration (rats), another common
86 g effects of cocaine and the opioid agonist, remifentanil, tested under intravenous self-administrati
87 ppressed respiration (ON-State) or high-dose remifentanil that completely inhibited breathing (OFF-St
88 uman subjects who were treated with low-dose remifentanil that suppressed respiration (ON-State) or h
89           We administered the opioid agonist remifentanil to human subjects during experimental therm
90                            Results comparing remifentanil versus PL show that PL group exhibit greate
91 ture response was substantially reduced when remifentanil was administered.
92                                     Although remifentanil was statistically inferior to neuromuscular
93  resonance imaging and the mu-opioid agonist remifentanil, we found that the magnitude of behavioral
94 ion (increased demand elasticity; alpha) for remifentanil without affecting remifentanil consumption
95                         We hypothesized that remifentanil would differentially depress brain areas th